Search research articles
Contact Us
Filters
Showing results (81-90 of 149) with videos related to
Page
of 15
Sort By:
The Pediatric Infectious Disease Journal
|
April 10, 2008
Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose
Margaret B Rennels, Steven Black, Emily Jane Woo, et al.
The Pediatric Infectious Disease Journal
|
October 4, 2013
Clinical characteristics and direct medical cost of respiratory syncytial virus infection in children hospitalized in Suzhou, China
Tao Zhang, Qiuli Zhu, Xuelan Zhang, et al.
BMJ Global Health
|
May 20, 2021
Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions
Caitlin Dodd, Nick Andrews, Helen Petousis-Harris, et al.
Plos One
|
September 8, 2012
The clinical characteristics and direct medical cost of influenza in hospitalized children: a five-year retrospective study in Suzhou, China
Tao Zhang, Qiuli Zhu, Xuelan Zhang, et al.
Vaccines
|
January 10, 2019
Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study
Janine Paynter, Felicity Goodyear-Smith, Jane Morgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
The Safety of PsA-TT in Pregnancy: An Assessment Performed Within the Navrongo Health and Demographic Surveillance Site in Ghana
George Wak, John Williams, Abraham Oduro, et al.
The Pediatric Infectious Disease Journal
|
April 7, 2007
A role for genetics in the immune response to the varicella vaccine
Nicola P Klein, Bruce Fireman, Andrea Enright, et al.
Vaccines
|
March 17, 2019
Reply to "Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005"
Janine Paynter, Felicity Goodyear-Smith, Jane Morgan, et al.
Lancet (London, England)
|
January 23, 2018
Pitfalls of the healthy vaccinee effect - Authors' reply
Helen Petousis-Harris, Janine Paynter, Jane Morgan, et al.
The Pediatric Infectious Disease Journal
|
March 5, 2008
Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age
Steven Black, Leonard R Friedland, Kathleen Ensor, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 149) with videos related to
Sort By:
Page
of 15
The Pediatric Infectious Disease Journal
|
April 10, 2008
Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose
Margaret B Rennels, Steven Black, Emily Jane Woo, et al.
The Pediatric Infectious Disease Journal
|
October 4, 2013
Clinical characteristics and direct medical cost of respiratory syncytial virus infection in children hospitalized in Suzhou, China
Tao Zhang, Qiuli Zhu, Xuelan Zhang, et al.
BMJ Global Health
|
May 20, 2021
Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions
Caitlin Dodd, Nick Andrews, Helen Petousis-Harris, et al.
Plos One
|
September 8, 2012
The clinical characteristics and direct medical cost of influenza in hospitalized children: a five-year retrospective study in Suzhou, China
Tao Zhang, Qiuli Zhu, Xuelan Zhang, et al.
Vaccines
|
January 10, 2019
Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study
Janine Paynter, Felicity Goodyear-Smith, Jane Morgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
The Safety of PsA-TT in Pregnancy: An Assessment Performed Within the Navrongo Health and Demographic Surveillance Site in Ghana
George Wak, John Williams, Abraham Oduro, et al.
The Pediatric Infectious Disease Journal
|
April 7, 2007
A role for genetics in the immune response to the varicella vaccine
Nicola P Klein, Bruce Fireman, Andrea Enright, et al.
Vaccines
|
March 17, 2019
Reply to "Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005"
Janine Paynter, Felicity Goodyear-Smith, Jane Morgan, et al.
Lancet (London, England)
|
January 23, 2018
Pitfalls of the healthy vaccinee effect - Authors' reply
Helen Petousis-Harris, Janine Paynter, Jane Morgan, et al.
The Pediatric Infectious Disease Journal
|
March 5, 2008
Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age
Steven Black, Leonard R Friedland, Kathleen Ensor, et al.
Page
of 15